<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotechnology Patent Law Blog &#124; Patents4Life by Warren Woessner &#187; Prosecution History Estopped</title>
	<atom:link href="http://www.patents4life.com/category/prosecution-history-estopped/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patents4life.com</link>
	<description></description>
	<lastBuildDate>Tue, 31 Jan 2012 14:44:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.4</generator>
	<atom:link rel='hub' href='http://www.patents4life.com/?pushpress=hub'/>
		<item>
		<title>Federal Circuit Reverses District Court&#039;s Finding that Generic Eloxatins do not Infringe Sanofi&#039;s Patent</title>
		<link>http://www.patents4life.com/2009/09/federal-circuit-reverses-district-courts-finding-that-generic-eloxatins-do-not-infringe-sanofis-patent/</link>
		<comments>http://www.patents4life.com/2009/09/federal-circuit-reverses-district-courts-finding-that-generic-eloxatins-do-not-infringe-sanofis-patent/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 20:07:00 +0000</pubDate>
		<dc:creator>Warren Woessner</dc:creator>
				<category><![CDATA[Prosecution History Estopped]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[eloxatins]]></category>
		<category><![CDATA[HPLC]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[oxaliplatin]]></category>
		<category><![CDATA[patenability]]></category>
		<category><![CDATA[patent profanity]]></category>
		<category><![CDATA[sanofi]]></category>
		<category><![CDATA[sanofi's patent]]></category>
		<category><![CDATA[Warren Woessner]]></category>

		<guid isPermaLink="false">http://www.patents4life.com/2009/09/federal-circuit-reverses-district-courts-finding-that-generic-eloxatins-do-not-infringe-sanofis-patent/</guid>
		<description><![CDATA[In my June 22, 2009 post, I discussed the district court decision that found a claim to optically-pure oxaliplatin (U.S. Pat. No 5,338,874) not infringed by defendants who made it by processes other than the HPLC process disclosed in the specification. I noted that this was an extreme case of &#8220;patent profanity&#8221; being used against [...]]]></description>
		<wfw:commentRss>http://www.patents4life.com/2009/09/federal-circuit-reverses-district-courts-finding-that-generic-eloxatins-do-not-infringe-sanofis-patent/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>COURT “CUSSES OUT” SANOFI – HOLDS OXALIPLATIN PATENT NOT INFRINGED</title>
		<link>http://www.patents4life.com/2009/06/court-%e2%80%9ccusses-out%e2%80%9d-sanofi-%e2%80%93-holds-oxaliplatin-patent-not-infringed/</link>
		<comments>http://www.patents4life.com/2009/06/court-%e2%80%9ccusses-out%e2%80%9d-sanofi-%e2%80%93-holds-oxaliplatin-patent-not-infringed/#comments</comments>
		<pubDate>Mon, 22 Jun 2009 17:09:00 +0000</pubDate>
		<dc:creator>Warren Woessner</dc:creator>
				<category><![CDATA[Prosecution History Estopped]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[oxaliplatin]]></category>
		<category><![CDATA[patent strategy]]></category>
		<category><![CDATA[patents]]></category>
		<category><![CDATA[Tom Irving]]></category>
		<category><![CDATA[Warren Woessner]]></category>

		<guid isPermaLink="false">http://www.patents4life.com/2009/06/court-%e2%80%9ccusses-out%e2%80%9d-sanofi-%e2%80%93-holds-oxaliplatin-patent-not-infringed/</guid>
		<description><![CDATA[For some years, Tom Irving of Finnegan Farabow, et al. has been giving a very amusing, but increasingly serious, talk about the dangers of what he calls “Patent Profanity.” The version I heard in May was, “Patently Profane at You and Your Client’s Peril.” He warns that the specification and prosecution history will be used [...]]]></description>
		<wfw:commentRss>http://www.patents4life.com/2009/06/court-%e2%80%9ccusses-out%e2%80%9d-sanofi-%e2%80%93-holds-oxaliplatin-patent-not-infringed/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

